She holds a bachelor's degree in molecular, cellular, and developmental biology from the University of Colorado, Boulder and a doctorate in pharmacoeconomics from the University of Colorado School of Pharmacy. Her research focuses on innovative approaches for decision-analytic modeling for economic and health outcomes assessments -- methods that she has applied to model medication adherence and translate pharmacometric findings to cost-effectiveness analyses. Before returning to academia, she worked in the field of drug discovery at Array BioPharma in Boulder. She is very active with the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and maintains close connections with collaborators in industry and academia alike. She is the course manager of REGS 641 Regulated Products in the Marketplace.